Invesco Ltd. - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 283 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,083,820
-22.4%
65,902
+0.1%
0.00%0.0%
Q2 2023$2,685,852
-0.6%
65,862
-9.2%
0.00%0.0%
Q1 2023$2,702,820
-81.5%
72,520
-82.6%
0.00%
-75.0%
Q4 2022$14,579,763
-35.6%
417,878
+3.3%
0.00%
-42.9%
Q3 2022$22,641,000
+10.4%
404,579
+2.1%
0.01%
+16.7%
Q2 2022$20,515,000
-27.4%
396,340
+2.0%
0.01%
-14.3%
Q1 2022$28,244,000
-50.0%
388,681
-18.6%
0.01%
-50.0%
Q4 2021$56,449,000
-37.3%
477,405
-28.9%
0.01%
-39.1%
Q3 2021$90,040,000
-18.8%
671,196
-2.0%
0.02%
-14.8%
Q2 2021$110,849,000
+12.2%
684,631
-44.4%
0.03%
+3.8%
Q1 2021$98,839,000
+21.9%
1,231,564
-17.4%
0.03%
+8.3%
Q4 2020$81,107,000
+1188.2%
1,490,949
+370.8%
0.02%
+1100.0%
Q3 2020$6,296,000
+532.1%
316,701
+568.0%
0.00%
Q2 2020$996,000
+308.2%
47,407
+138.0%
0.00%
Q1 2020$244,000
-6.9%
19,922
+11.4%
0.00%
Q4 2019$262,000
+3.1%
17,888
-6.2%
0.00%
Q3 2019$254,000
-21.6%
19,063
-3.8%
0.00%
Q2 2019$324,000
-7.4%
19,807
-3.3%
0.00%
Q1 2019$350,000
-93.8%
20,482
-92.4%
0.00%
-100.0%
Q1 2018$5,664,000
+301.1%
268,551
+223.7%
0.00%
Q3 2016$1,412,000
-20.3%
82,974
-0.0%
0.00%
-100.0%
Q2 2016$1,771,00082,9940.00%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Discovery Value Fund 561,561$17,756,5599.73%
MPM BioImpact LLC 544,639$17,221,4854.60%
Casdin Capital, LLC 1,178,075$37,250,7324.12%
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 1,145,091$36,207,7773.72%
Atlas Venture Associates IX, LLC 10,000$316,2002.69%
Deep Track Capital, LP 2,000,000$63,240,0002.44%
ARK Investment Management 9,948,629$314,575,6382.41%
Merlin Capital, Inc 18,526$585,7922.19%
Orchard Capital Management, LLC 159,155$5,032,4811.86%
TANG CAPITAL MANAGEMENT LLC 397,600$12,572,1121.77%
View complete list of INTELLIA THERAPEUTICS INC shareholders